Three-month evaluation of dorzolamide hydrochloride/timolol maleate fixed-combination eye drops versus the separate use of both drugs

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Japanese Journal of Ophthalmology

• Publication date

  2012-09-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10384-012-0186-8PMID 23001284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Double-masked, phase III comparative study of the combination ophthalmic solution of the 1% dorzolamide hydrochloride/0.5% timolol maleate (MK-0507A) in patients with glaucoma and ocular hypertension].

  2011cited by this paper
• Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma

  2011cited by this paper
• Determinants of Adherence to Glaucoma Medical Therapy in a Long-term Patient Population

  2009cited by this paper
• Determinants of adherence to glaucoma medical therapy in a long-term patient population.

  2009cited by this paper
• Comparison of Daytime Efficacy and Safety of Dorzolamide/Timolol Maleate Fixed Combination versus Latanoprost

  2008cited by this paper
• Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.

  2008cited by this paper
• A Comparison of Travoprost, Latanoprost, and the Fixed Combination of Dorzolamide and Timolol in Patients with Pseudoexfoliation Glaucoma

  2006cited by this paper
• A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.

  2006cited by this paper
• A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.

  2004cited by this paper
• Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

  2004cited by this paper
• The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.

  2003cited by this paper
• Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.

  2003cited by this paper
• Influence of dorzolamide on corneal endothelium.

  2003cited by this paper
• The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma

  2002cited by this paper
• A comparison of the effects on intraocular pressure of latanoprost 0.005% and the fixed combination of dorzolamide 2% and timolol 0.5% in patients with open-angle glaucoma.

  2002cited by this paper
• The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

  2000cited by this paper
• The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration

  2000cited by this paper
• A comparison of dorzolamide-timolol combination versus the concomitant drugs.

  2000cited by this paper
• The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group.

  1998cited by this paper
• The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.

  1998cited by this paper
• The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.

  1998cited by this paper
• Dorzolamide, a topical carbonic anhydrase inhibitor: a two-week dose-response study in patients with glaucoma or ocular hypertension.

  1994cited by this paper

• Improvement of corneal epithelial damage after switching from the concomitant use of brinzolamide and brimonidine to a brinzolamide/brimonidine fixed-dose combination

  2024influential citation
• Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online

  2023cites this paper
• A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications

  2022cites this paper
• A comparative study of topical fixed dose combination of brimonidine (0.2%) plus brinzolamide (1%) versus brimonidine (0.2%) plus timolol (0.5%) in patients of primary open angle glaucoma

  2021cites this paper
• A comparative study on the efficacy of brinzolamide/timolol versus brinzolamide/brimonidine fixed drug combinations in primary open-angle glaucoma

  2020cites this paper
• Comparison of different combinations of maximum medical therapy for lowering intraocular pressure in primary open angle glaucoma: 12-month retrospective consecutive case series

  2019cites this paper
• Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement

  2019cites this paper
• CEOR_A_218277 591..604

  2019cites this paper
• The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study

  2018cites this paper
• The Efficacy of Brinzolamide 1%/Brimonidine 0.2% Fixed Combination in Normal Tension Glaucoma

  2016cites this paper
• Opportunities for the Development of Newer Drugs for Ocular Use

  2016cites this paper
• Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension

  2015cites this paper
• Anterior segment optical coherence tomography for demonstrating posterior capsular rent in posterior polar cataract

  2014cites this paper
• Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension

  2014cites this paper
• Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma

  2014cites this paper
• Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice

  2014cites this paper
• Chapter 21 - Diuretics

  2014cites this paper
• Clinical Ophthalmology Dovepress

  year unknowncites this paper
• Journal of Health Economics and Outcomes Research

  year unknowncites this paper
• Clinical Ophthalmology Dovepress Safety and Efficacy of a Fixed versus Unfixed Brinzolamide/timolol Combination in Japanese Patients with Open-angle Glaucoma or Ocular Hypertension

  year unknowncites this paper
• Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension

  year unknowncites this paper